3/24
04:05 pm
bsem
BioStem Technologies Reports Fourth Quarter and Full Year 2025 Financial Results
Neutral
Report
BioStem Technologies Reports Fourth Quarter and Full Year 2025 Financial Results
3/23
07:00 am
bsem
BioStem Appoints Jodi Ungrodt to Board of Directors as Audit Committee Chair
Medium
Report
BioStem Appoints Jodi Ungrodt to Board of Directors as Audit Committee Chair
3/20
08:07 am
bsem
BioStem Technologies (BSEM) was upgraded by Zacks Research to "hold".
Low
Report
BioStem Technologies (BSEM) was upgraded by Zacks Research to "hold".
3/11
04:05 pm
bsem
BioStem Technologies to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on March 24, 2026
Low
Report
BioStem Technologies to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on March 24, 2026
2/20
07:00 am
bsem
BioStem Technologies to Present at the 46th Annual TD Cowen Healthcare Conference
Low
Report
BioStem Technologies to Present at the 46th Annual TD Cowen Healthcare Conference
2/3
04:05 pm
bsem
BioStem Technologies Highlights Alignment with FDA’s Openness to Bayesian Statistical Approaches in Clinical Research
Medium
Report
BioStem Technologies Highlights Alignment with FDA’s Openness to Bayesian Statistical Approaches in Clinical Research
1/21
05:30 pm
bsem
BioStem Technologies Advances Entry into the Acute Wound Care Market with Acquisition of BioTissue Holdings’ Surgical and Wound Care Business
High
Report
BioStem Technologies Advances Entry into the Acute Wound Care Market with Acquisition of BioTissue Holdings’ Surgical and Wound Care Business
1/7
04:05 pm
bsem
BioStem Technologies Comments on Withdrawal of CMS CY 2026 Final Medicare Reimbursement Rule for Skin Substitutes
High
Report
BioStem Technologies Comments on Withdrawal of CMS CY 2026 Final Medicare Reimbursement Rule for Skin Substitutes